Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Wendell Wierenga

Director at Cytokinetics Inc (CYTK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M

Reported trades

Filed Stock Type Shares Price Value Since
May 5SEC CYTKCytokinetics Inc Sell Plan 4,03232,637 held (−11%) $75.00 $302K -17.4%
Dec 23SEC CYTKCytokinetics Inc Sell Plan 20,00032,444 held (−38%) $66.14 $1.3M -6.3%
Oct 27SEC CYTKCytokinetics Inc Sell Plan 4,37532,444 held (−12%) $58.68 $257K +5.6%
  • Sell

    Director Wendell Wierenga sold $302K of CYTK at $75.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Wendell Wierenga sold $1.3M of CYTK at $66.14 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Wendell Wierenga sold $257K of CYTK at $58.68 — pre-scheduled 10b5-1 plan sale.